Grace Therapeutics, Inc. Cash Flow Quality Index
Grace Therapeutics, Inc. cash flow quality index. Grace Therapeutics, Inc. (GRCE) has a Cash Flow Quality Index of -4.64x as of March 2025. Operating cash flow of $-2.95 Million is below net income of $636.00K, suggesting accrual-heavy earnings not yet converted to cash. See Grace Therapeutics, Inc. (GRCE) flexibility index to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Grace Therapeutics, Inc. Cash Flow Quality Index by Year (None–None)
Grace Therapeutics, Inc. cash flow quality index by year from None to None. Year-by-year earnings quality comparison for Grace Therapeutics, Inc.. For the full cash flow conversion analysis, see Grace Therapeutics, Inc. (GRCE) cash flow conversion.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|